PT  - JOURNAL ARTICLE
AU  - Bastien Reyné
AU  - Christian Selinger
AU  - Mircea T Sofonea
AU  - Stéphanie Miot
AU  - Amandine Pisoni
AU  - Edouard Tuaillon
AU  - Jean Bousquet
AU  - Hubert Blain
AU  - Samuel Alizon
TI  - Wearing masks and establishing COVID-19 areas reduces secondary attack risk in nursing homes
AID  - 10.1101/2020.11.27.20239913
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.27.20239913
4099  - http://medrxiv.org/content/early/2020/12/02/2020.11.27.20239913.short
4100  - http://medrxiv.org/content/early/2020/12/02/2020.11.27.20239913.full
AB  - Background COVID-19 is spreading rapidly in nursing homes (NHs). It is urgent to evaluate the effect of infection prevention and control (IPC) measures to reduce COVID spreading.Methods We analysed COVID-19 outbreaks in 12 NH using rRT-PCR for SARS-CoV-2. We estimated secondary attack risks (SARs) and identified cofactors associated with the proportion of infected residents.Results The SAR was below 5%, suggesting a high efficiency of IPC measures. Mask-wearing or establishment of COVID-19 zones for infected residents were associated with lower SAR.Conclusions Wearing masks and isolating potentially infected residents appear to limit SARS-CoV-2 spread in nursing homes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis observational study was approved by the Internal Review Board from the Montpellier University Hospital (IRB-MTP_2020_06_202000534).Funding StatementThis work was partly supported by the Occitanie region and the ANR (grant PhyEpi).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This observational study was approved by the Internal Review Board from the Montpellier University Hospital (IRB-MTP_2020_06_202000534).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data will be published along with the article when accepted.